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The response to HIV in sub-Saharan Africa (SSA) in 
the past decade has resulted in one of the largest and 
most dramatic health interventions in recent history,1 
with the provision of antiretroviral therapy (ART) both as 
treatment to infected adults and children and to prevent 
vertical transmission of HIV from mother to child.
Where monitoring systems have been able to track 
outcomes of large-scale ART programmes in SSA, they 
appear to be effective.2,3 However, outside of small 
demographic surveillance sites4-6 weak vital registration 
systems limit our ability to demonstrate the population-
level impact of these interventions. South Africa is 
unique in having a high burden of HIV disease together 
with one of the most complete vital registration systems 
on the continent, in which 80% of deaths are currently 
estimated to be registered.7
We have previously demonstrated in South Africa at a 
national level that infant deaths (at ages 1 - 11 months) 
increased over the period 1997 - 2002,8 with the greatest 
increase at 2 - 3 months of age. This peak in early 
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Objective. It has previously been demonstrated that a peak in registered infant deaths, at 2 - 3 months of age at 
death, developed between 1997 and 2002 in South Africa, alongside the evolving HIV epidemic. The objective of 
this analysis was to explore the age distribution of post-neonatal infant deaths in South Africa by province, and 
relate the observed distributions to HIV and intervention characteristics.
Design. Ecological study based on registered infant deaths and published HIV and intervention characteristics.
Methods. Numbers of registered infant deaths beyond 1 month of age at death were plotted by year of death, 
province of South Africa and age at death in months, for the years 1997 - 2007.
Results. The total number of registered deaths in infants aged 1 - 11 months increased from 15 404 in 1997 to 
34 479 in 2006. Eight of the 9 provinces experienced an annual peak in registered infant deaths at 2 - 3 months 
of age between 1997 and 2007. This peak in mortality was not observed in the Western Cape. In 7 of 9 provinces 
registered post-neonatal infant deaths did not rise markedly in 2007 compared with 2005.
Conclusions. We identified a single province out of 9 South African provinces in which a peak in early infant 
deaths at age 2 - 3 months did not occur during the period 1997 - 2007. This was the province with the earliest 
and highest coverage of antiretroviral interventions from 1999 onwards. It is possible that these interventions have 
averted the greater increase in early infant deaths seen in the rest of South Africa over this period. 
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infant deaths could not be ascribed solely to improving 
registration of deaths over time, and was consistent with 
cohort studies of HIV-infected infants.9-10
In this present analysis we describe post-neonatal 
infant mortality by age in months across the 9 provinces 
in South Africa from 1997 to 2007, and reflect on the 
relationship between the early peak in infant deaths 
and province-specific HIV epidemic and intervention 
characteristics.
SETTING
Antenatal HIV-1 seroprovalence had reached 17.0% in 
pregnant women in South Africa by 1996, rose steadily 
to 30.2% by 2005, and has subsequently remained 
around this level.11 In 2005, the HIV seroprevalence 
varied between provinces from 15.7% in the Western 
Cape to 39.1% in KwaZulu-Natal (Table I). There have 
also been large inter-provincial variations in both timing 
and coverage of antiretroviral interventions in South 
Africa.12
METHODS
We obtained South African infant mortality counts by 
age at death for the period 1997 - 2007 from Statistics 
South Africa. Infant deaths under 1 month were excluded 
from analysis because of the potential misclassification 
of live and stillbirths. Absolute counts of infant deaths 
were considered by province, year and age at death 
in months, starting at 1 month of age. For graphical 
presentation purposes, counts were averaged across the 
periods 1997 - 1999, 2000 - 2001, 2002 - 2003, 2004 - 
2005 and 2006 - 2007. All analyses were conducted 
using Stata statistical software v11.0 (Stata-Corp Inc, 
College Station, Texas). The study was approved by the 
University of Cape Town Research Ethics Committee.
RESULTS
The total number of registered deaths in infants aged 
1 - 11 months increased from 15 404 in 1997 to 34 479 
in 2006 (32 828 in 2007). Eight of the 9 provinces 
experienced an annual peak in registered infant deaths 
at 2 - 3 months of age between 1997 and 2007 (Fig. 1). 
This peak in mortality was not observed in the Western 
Cape. In 7 of 9 provinces registered post-neonatal infant 
deaths did not rise markedly in 2007 compared with 2005 
(Table I). Expressed as a ratio to deaths at 11 months 
of age (which compensates for increasing registration 
over time), this peak was still present in 2006 - 2007 in 
the 8 provinces where it was observed, but had declined 
in 5 compared with the ratios seen in previous calendar 
periods. 
DISCUSSION
Our previous study demonstrated, at a national level for 
the period 1997 - 2002, a year-on-year increase in infant 
mortality at each age of death (1 - 11 months), with the 
greatest increase at 2 - 3 months.8 This current analysis 
by province for the period 1997 - 2007 demonstrates the 
continued presence of a peak in infant deaths at 2 - 3 
months of age in the context of the evolving HIV epidemic 
in South Africa, with reported mortality stabilising in most 
Fig. 1. Registered post-neonatal deaths in South African infants by age in months, province and year of death registration 
(note that the scale differs between provinces).
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provinces in 2006 - 2007. The analysis further identifies 
the absence of a peak in mortality at 2 - 3 months in the 
Western Cape. 
The rapid rise in registered deaths over the period 
1997 - 2005 is largely attributable to improvements in 
the registration of infant deaths,13 but could also in part 
be due to increasing levels of maternal HIV prevalence 
(Table I), which have led to increasing levels of vertical 
HIV transmission and AIDS mortality. The absence of 
a further increase after 2005 in registered early infant 
deaths in 7 of the 9 provinces could potentially be 
ascribed to the slowing of the year-on-year increases in 
the completeness of infant death registration,13 the stable 
proportion of pregnant women with HIV since 2005, and 
the accelerated scale-up of prevention of mother-to-child 
transmission (PMTCT) and ART interventions after 2005 
(Table I). The absence of this peak in the Western Cape 
corresponds with a delayed provincial HIV epidemic, 
and exceptionally high coverage of pregnant women 
with PMTCT interventions of increasing effectiveness.
PMTCT was first introduced in the Western Cape in 
1999 in Khayelitsha,14 following the protocols that had 
been effective in Thailand.15 At the time this was the 
sub-district in the province with the highest antenatal 
HIV seroprevalence (22% in 2001).16 Between 2000 and 
2003, PMTCT interventions were extended to the rest 
of the province based on the HIVNET-012 protocols,17 
reaching universal availability and over 80% coverage 
in early 2003.18 By early 2004 the intervention had 
been intensified, combining antenatal zidovudine 
with peripartum nevirapine, and both nevirapine and 
zidovudine prophylaxis to neonates.19,20 In contrast, in 
other provinces PMTCT was only officially sanctioned 
in 18 pilot sites in 2001. In 2003 less than a quarter of 
pregnant women in South Africa received HIV testing, 
and less than half in 2005 (Table I),12 with more than 
a third of those testing HIV positive in these provinces 
in 2005 not receiving even the moderately effective 
single-dose nevirapine-based interventions that were 
available at the time.21 A plausible explanation for the 
absence of the peak in infant deaths at 2 - 3 months 
of age in the Western Cape is that by the time the 
proportion of pregnant women who were HIV-infected 
reached high levels, the majority were able to access 
PMTCT interventions, which increased in effectiveness 
over time. In addition to the high coverage of PMTCT 
in the province, the inclusion of antenatal zidovudine in 
provincial PMTCT protocols probably resulted in less 
intra-uterine vertical transmission, which is believed to 
contribute relatively more to early infant mortality than 
intrapartum and postpartum transmission.9,22 
EC FS GT KZN LP MP NC NW WC SA
Births (100 000s)* 2001 1.66 0.64 2.08 2.48 1.53 0.85 0.18 0.85 1.00 11.27
2003 1.61 0.63 2.10 2.45 1.52 0.84 0.18 0.84 1.01 11.15
2005 1.59 0.62 2.04 2.41 1.53 0.82 0.18 0.83 1.00 11.00
2007 1.61 0.61 1.94 2.38 1.55 0.82 0.18 0.82 0.99 10.84
Registered infant deaths,  
1 - 11 months (1 000s) 2001 1.97 2.43 5.06 5.09 1.08 1.60 0.55 2.59 1.36 21.72
2003 2.77 3.06 6.35 5.87 1.62 2.43 0.53 3.25 1.43 27.31
2005 3.47 3.88 7.09 7.07 2.50 3.13 0.51 4.13 1.55 33.33
2007 3.24 3.45 7.21 6.75 3.25 2.91 0.80 3.56 1.67 32.83
Antenatal HIV seroprevalence 
(%)† 2001 21.7 30.1 29.8 33.5 14.5 29.2 15.9 25.2 8.6 24.8
2003 27.1 30.1 29.6 37.5 17.5 32.6 16.7 29.9 13.1 27.9
2005 29.5 30.3 32.4 39.1 21.5 34.8 18.5 31.8 15.7 30.2
2007 26.0 33.5 30.3 37.4 18.5 32.0 16.1 29.0 16.1 28
HIV testing of pregnant women 
(%)‡ 2001 1.7 4.6 7.2 1.0 0.6 5.0 2.2 6.9
2003 31.1 17.6 26.0 10.9 18.2 86.0 25.3
2005 40.4 47.4 43.8 46.5 31.4 59.1 47.9 49.1
2007 75.3 80.1 73.3 70.7 90.1 74.6 88.5 85.6 95.7 81.0
Adult ART coverage (%)§ 2001 3.0 2.5 3.9 3.4 2.2 2.9 3.3 2.4 5.1 3.3
2003 5.2 2.9 10.0 4.6 3.0 4.2 5.8 3.4 33.9 6.7
2005 26.6 16.6 37.0 32.4 24.2 20.5 42.5 35.8 66.5 32.8
2007 40.9 36.8 58.4 56.5 47.7 44.0 81.3 40.7 89.2 54.0
Paediatric ART coverage (%)§ 2001 1.1 1.2 1.8 1.4 0.7 1.2 1.5 1.1 2.5 1.4
2003 2.3 1.7 6.9 2.2 1.2 1.8 3.9 1.6 36.8 3.9
2005 13.1 11.7 31.1 20.8 9.0 12.2 51.8 18.9 58.5 20.6
2007 26.8 22.1 46.0 30.6 35.9 29.4 96.1 50.7 96.9 36.9
TABLE I. BIRTHS, INFANT DEATHS, AND HIV AND ANTIRETROVIRAL INTERVENTION CHARACTERISTICS  
IN SOUTH AFRICA BY PROVINCE
*Source: Actuarial Society of South Africa AIDS and Demographic Model.24
†Source: Antenatal Surveys from the National Department of Health.25-27
‡Source: Child Gauge 2009.12 Value in italics is from an alternative source.18
§Coverage reflects the ratio of new enrolments to the number of individuals anticipated to be newly AIDS symptomatic in each year, based on (*) above.28 
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A decline in under-2 mortality has recently been 
described in a rural KwaZulu-Natal setting after 2004,4 
ascribed in part to the PMTCT programme that was 
rapidly scaled up in the surveillance area before the 
observed decline. The KwaZulu-Natal study found that 
the major part of this decline was in post-neonatal infant 
deaths, in keeping with the currently presented data.
The current study has a number of limitations. The 
ecological design cautions us to consider alternative 
explanations for our observations. As discussed, the 
lack of clarity on the completeness of infant death 
registration complicates the interpretation of these data. 
Further, we did not attempt to analyse mortality trends 
by cause of death, owing to the low proportion of HIV-
related deaths recorded as being due to HIV.23 We have, 
however, demonstrated previously that the peak at 2 - 
3 months of age was absent in the small proportion of 
infant deaths where HIV was unlikely to be related to the 
underlying cause.8
We have identified a single province out of 9 South 
African provinces in which a peak in early infant deaths 
at 2 - 3 months of age did not occur during the period 
1997 - 2007. This was the province with the earliest 
and highest coverage of ARV interventions from 1999 
onwards.  It is possible that these interventions have 
averted the greater increase in early infant deaths seen 
in the rest of South Africa over this period. Prospective 
monitoring of the age pattern of infant deaths by province 
could in future prove an important tool for assessing 
the impact of ARV and PMTCT interventions on child 
survival in South Africa as the completeness of infant 
death registration stabilises, and the coverage and 
effectiveness of interventions are further intensified.
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We dedicate this report to the memory of our friend 
and colleague, David Bourne, who died unexpectedly 
in February 2009. David worked as a statistician and 
demographer in the School of Public Health and Family 
Medicine at the University of Cape Town for over 30 
years, and was a passionate voice in describing the 
impact of HIV in South Africa.  In recent years he 
became increasingly interested in the use of routine 
surveillance to track the evolving HIV epidemic, and 
in particular the age distribution of infant deaths, 
initiating among others this analysis, which was in 
process at the time of his death.
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